COVID-19 Lessons Learned: Examining the Costs and Challenges for Managed Care Organizations and Health Systems Web Activity


Vanita Pindolia, PharmD, MBA
Vice President, Ambulatory
Clinical Pharmacy Programs
Henry Ford Health System (HFHS)
Health Alliance Plan (HAP)
Click here for biography

Peter Watson, MD, MMM, FACP, SFHM
Vice President, Care Management
Quality and Outcomes
Health Alliance Plan (HAP)
Medical Director, HAP/HAP Empowered
Attending Staff Hospitalist, 
Henry Ford Medical Group
Click here for biography

Mayur Ramesh, MD
Senior Staff Physician,
Infectious Diseases
Henry Ford Health System (HFHS)
Click here for biography



The overall response to the COVID-19, the disease caused by SARS-CoV-2, demonstrated the lack of preparedness that many organizations had for a health care pandemic. Lessons learned from the COVID-19 crisis can serve valuable guidance for managed care organizations (MCOs) and various health systems so that they can better prepare for a pandemic situation.  Several strategies emerged during the COVID-19 pandemic that are important to utilize and to optimize costs and resource utilization during pandemic situations. These include the increased use of telehealth, increased home delivery of medications, early refills, as well as transferring patients to homecare when possible. This educational activity is designed to improve the knowledge and competence among managed care and health system professionals regarding the need to develop a pandemic preparedness plan that includes these strategies to reduce cost and provide optimal patient care during a pandemic.

Educational Objectives 
At the conclusion of this activity, participants should be able to demonstrate improved ability to: 


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour (0.10 CEU) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-20-2191-H01-P
Type of Activity: Knowledge

Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Name of Faculty or Presenter Reported Financial Relationship
Vanita Pindolia, PharmD, MBA

Consulting Fee: Continuous Glucose Monitors-Dexcom Inc.

Mayur Ramesh, MD

Dr. Ramesh has nothing to disclose.

Peter Watson, MD, MMM, FACP, SFHM

Dr. Watson has nothing to disclose.

The PIM planners and managers have nothing to disclose.
The Impact Education, LLC® planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

There are no fees for participating and receiving CME/CE credit for this activity. During the period of accreditation participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, you may immediately submit your CPE credit to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account. Credit must be uploaded to CPE Monitor within 30 days.


There is no fee for this educational activity.